SI1227088T1 - Crystalline base of citalopram and hydrochoride or hydrobromide salt thereof - Google Patents

Crystalline base of citalopram and hydrochoride or hydrobromide salt thereof

Info

Publication number
SI1227088T1
SI1227088T1 SI200130031T SI200130031T SI1227088T1 SI 1227088 T1 SI1227088 T1 SI 1227088T1 SI 200130031 T SI200130031 T SI 200130031T SI 200130031 T SI200130031 T SI 200130031T SI 1227088 T1 SI1227088 T1 SI 1227088T1
Authority
SI
Slovenia
Prior art keywords
hydrochoride
citalopram
hydrobromide salt
crystalline base
crystalline
Prior art date
Application number
SI200130031T
Other languages
English (en)
Slovenian (sl)
Inventor
Hans Petersen
Klaus Peter B�ges�
Per Holm
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8159320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1227088(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of SI1227088T1 publication Critical patent/SI1227088T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Laminated Bodies (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200130031T 2000-03-13 2001-02-28 Crystalline base of citalopram and hydrochoride or hydrobromide salt thereof SI1227088T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200000402 2000-03-13
DKPCT/DK00/00183 2000-04-13
EP02009350A EP1227088B1 (en) 2000-03-13 2001-02-28 Crystalline base of citalopram and hydrochoride or hydrobromide salt thereof

Publications (1)

Publication Number Publication Date
SI1227088T1 true SI1227088T1 (en) 2003-12-31

Family

ID=8159320

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200130001T SI1169314T2 (sl) 2000-03-13 2001-02-28 Kristaliniäśna baza citaloprama
SI200130031T SI1227088T1 (en) 2000-03-13 2001-02-28 Crystalline base of citalopram and hydrochoride or hydrobromide salt thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200130001T SI1169314T2 (sl) 2000-03-13 2001-02-28 Kristaliniäśna baza citaloprama

Country Status (42)

Country Link
US (7) US20010031784A1 (xx)
EP (2) EP1169314B2 (xx)
JP (1) JP2003527383A (xx)
KR (1) KR20020080486A (xx)
CN (2) CN1258530C (xx)
AR (1) AR029811A1 (xx)
AT (3) ATE223396T1 (xx)
AU (2) AU746664B2 (xx)
BE (1) BE1013210A3 (xx)
BG (1) BG107065A (xx)
BR (1) BR0109373A (xx)
CA (2) CA2360287C (xx)
CH (2) CH691537A5 (xx)
CZ (1) CZ292077B6 (xx)
DE (7) DE20007303U1 (xx)
DK (3) DK173903B1 (xx)
EA (1) EA200200972A1 (xx)
ES (3) ES2180471T3 (xx)
FI (2) FI20010156A0 (xx)
FR (1) FR2806086B1 (xx)
GB (2) GB2357762B (xx)
GR (1) GR1003796B (xx)
HK (1) HK1054750A1 (xx)
HR (1) HRP20020756A2 (xx)
HU (3) HU0001581D0 (xx)
IE (1) IES20010109A2 (xx)
IL (2) IL147339A (xx)
IS (1) IS5841A (xx)
IT (2) IT1319645B1 (xx)
MX (1) MXPA02008793A (xx)
NL (2) NL1016435C1 (xx)
NO (2) NO312031B1 (xx)
PL (1) PL360158A1 (xx)
PT (2) PT1227088E (xx)
SE (2) SE517136C2 (xx)
SI (2) SI1169314T2 (xx)
SK (1) SK285528B6 (xx)
TR (1) TR200202185T2 (xx)
UA (1) UA74360C2 (xx)
WO (1) WO2001068627A1 (xx)
YU (1) YU68802A (xx)
ZA (1) ZA200207148B (xx)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100604156B1 (ko) 1999-04-14 2006-07-25 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US7713279B2 (en) 2000-12-20 2010-05-11 Fox Hollow Technologies, Inc. Method and devices for cutting tissue
US6299622B1 (en) 1999-08-19 2001-10-09 Fox Hollow Technologies, Inc. Atherectomy catheter with aligned imager
US7708749B2 (en) 2000-12-20 2010-05-04 Fox Hollow Technologies, Inc. Debulking catheters and methods
US7771444B2 (en) 2000-12-20 2010-08-10 Fox Hollow Technologies, Inc. Methods and devices for removing material from a body lumen
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
US7887556B2 (en) 2000-12-20 2011-02-15 Fox Hollow Technologies, Inc. Debulking catheters and methods
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
GB2376233B (en) * 2000-08-10 2003-09-10 Lundbeck & Co As H Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
ATE277920T1 (de) * 2000-12-22 2004-10-15 Lundbeck & Co As H Verfahren zur vorbereitung von reinem citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
IL158031A0 (en) * 2001-05-01 2004-03-28 Lundbeck & Co As H The use of enantiomeric pure escitalopram
DE60202615T2 (de) 2001-07-31 2006-01-12 H. Lundbeck A/S Kristalline zusammensetzung mit escitalopram
AU2003222435A1 (en) * 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
GB2386118A (en) * 2002-02-27 2003-09-10 Cipla Ltd Citalopram
GB2387844B (en) * 2002-02-27 2005-05-11 Matrix Lab Ltd Separation of impurities from a crude mixture of citalopram
GB2386119A (en) * 2002-02-27 2003-09-10 Cipla Ltd Purification of citalopram
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2385848A (en) * 2002-02-27 2003-09-03 Cipla Ltd Citalopram salts
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
WO2004094399A1 (en) * 2003-04-21 2004-11-04 Natco Pharma Ltd An improved process for the preparation of citalopram hydrobromide
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
EP1486492A3 (en) * 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
GB0317475D0 (en) * 2003-07-25 2003-08-27 Meditab Specialities Pvt Ltd Product
JP4025735B2 (ja) * 2003-08-21 2007-12-26 ローム アンド ハース カンパニー 水性系を処理する方法
GB0320312D0 (en) 2003-08-29 2003-10-01 Novartis Ag Purification process
CN100569765C (zh) 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
ITTO20050301A1 (it) * 2005-05-05 2006-11-06 Errekappa Euroterapici Spa Formulazioni liquide orali contenenti citalopram
EP1901714A2 (en) * 2005-05-20 2008-03-26 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
WO2007002597A2 (en) 2005-06-27 2007-01-04 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
US20070276419A1 (en) 2006-05-26 2007-11-29 Fox Hollow Technologies, Inc. Methods and devices for rotating an active element and an energy emitter on a catheter
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
JP5555242B2 (ja) 2008-10-13 2014-07-23 コヴィディエン リミテッド パートナーシップ カテーテルシャフトを操作するデバイスおよび方法
JP5579830B2 (ja) 2009-04-29 2014-08-27 コヴィディエン リミテッド パートナーシップ 組織を切断および研磨する方法および装置
WO2010132748A1 (en) 2009-05-14 2010-11-18 Fox Hollow Technologies, Inc. Easily cleaned atherectomy catheters and methods of use
CA2781046C (en) 2009-12-02 2014-09-16 Tyco Healthcare Group Lp Methods and devices for cutting tissue
RU2520801C2 (ru) 2009-12-11 2014-06-27 ТАЙКО ХЕЛСКЕА ГРУП эЛПи Устройство для съема материала с улучшенной эффективностью захвата и способы применения
CA2800920C (en) 2010-06-14 2015-04-14 Covidien Lp Material removal device
US8920450B2 (en) 2010-10-28 2014-12-30 Covidien Lp Material removal device and method of use
US8808186B2 (en) 2010-11-11 2014-08-19 Covidien Lp Flexible debulking catheters with imaging and methods of use and manufacture
EP2750862B1 (en) 2011-09-01 2016-07-06 Covidien LP Catheter with helical drive shaft and methods of manufacture
US9532844B2 (en) 2012-09-13 2017-01-03 Covidien Lp Cleaning device for medical instrument and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
WO2015200702A1 (en) 2014-06-27 2015-12-30 Covidien Lp Cleaning device for catheter and catheter including the same
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
CN114375191A (zh) 2019-07-19 2022-04-19 比奥克斯塞尔医疗股份有限公司 非镇静的右美托咪定治疗方案
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2233970A (en) * 1941-03-04 Quinoline compound and process of
US2584429A (en) * 1950-12-29 1952-02-05 Rohm & Haas 1,1-diphenyl-4-tert.-amino-2-butyne-1-ols
GB1143702A (xx) * 1965-03-18
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DK213290D0 (da) 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
AU737610B2 (en) * 1997-07-08 2001-08-23 H. Lundbeck A/S Method for the preparation of citalopram
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CA2291072C (en) * 1997-11-11 2002-08-20 H. Lundbeck A/S Method for the preparation of citalopram
NZ510858A (en) * 1998-10-20 2003-11-28 H Method for the preparation of citalopram
KR100604156B1 (ko) 1999-04-14 2006-07-25 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
US6433196B1 (en) * 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof

Also Published As

Publication number Publication date
CH691537A5 (de) 2001-08-15
US20060247451A1 (en) 2006-11-02
ES2173054T3 (es) 2002-12-16
DE20121240U1 (de) 2002-07-04
CZ292077B6 (cs) 2003-07-16
ZA200207148B (en) 2003-04-23
NO312031B1 (no) 2002-03-04
HRP20020756A2 (en) 2004-12-31
FI109022B (fi) 2002-05-15
NL1016435C1 (nl) 2000-11-06
NO20020356L (no) 2001-09-14
HU0100531D0 (en) 2001-03-28
IS5841A (is) 2001-09-14
AT4364U1 (de) 2001-06-25
CA2411732A1 (en) 2001-09-20
DE60100786D1 (de) 2003-10-23
TR200202185T2 (tr) 2002-12-23
GB0102797D0 (en) 2001-03-21
ES2159491B1 (es) 2002-05-01
IL147339A (en) 2004-09-27
EP1169314B2 (en) 2011-06-01
SI1169314T1 (en) 2002-12-31
ATE250050T1 (de) 2003-10-15
DE60100022T3 (de) 2011-11-17
CN1258530C (zh) 2006-06-07
EP1169314A1 (en) 2002-01-09
SE0103046D0 (sv) 2001-09-14
PL360158A1 (en) 2004-09-06
SK285528B6 (sk) 2007-03-01
IT1319645B1 (it) 2003-10-23
EP1169314B1 (en) 2002-09-04
WO2001068627A1 (en) 2001-09-20
HU0001581D0 (en) 2000-06-28
CN1680350A (zh) 2005-10-12
CZ2001808A3 (cs) 2002-01-16
UA74360C2 (uk) 2005-12-15
US20050165092A1 (en) 2005-07-28
EP1227088B1 (en) 2003-09-17
BR0109373A (pt) 2002-12-24
DE1227088T1 (de) 2003-02-06
FR2806086A1 (fr) 2001-09-14
ES2173054T1 (es) 2002-10-16
PT1169314E (pt) 2002-11-29
JP2003527383A (ja) 2003-09-16
AU3725201A (en) 2001-09-13
KR20020080486A (ko) 2002-10-23
IES20010109A2 (en) 2002-02-20
ES2180471T1 (es) 2003-02-16
AU2001100197B4 (en) 2001-12-06
SK13132002A3 (sk) 2003-01-09
SE0103046L (sv) 2001-11-14
FI20010156A0 (fi) 2001-01-25
CN1429220A (zh) 2003-07-09
US20040167210A1 (en) 2004-08-26
ES2180471T3 (es) 2004-05-01
CA2360287A1 (en) 2001-09-20
GB2357762B (en) 2002-01-30
SI1169314T2 (sl) 2011-08-31
HK1054750A1 (en) 2003-12-12
SE0200730L (sv) 2002-08-29
IL147339A0 (en) 2002-08-14
CH691477A5 (de) 2001-07-31
MXPA02008793A (es) 2003-02-12
NL1017413C1 (nl) 2001-09-13
DE10164687B4 (de) 2006-04-27
HU0100450D0 (en) 2001-04-28
AU746664B2 (en) 2002-05-02
NO315851B1 (no) 2003-11-03
AR029811A1 (es) 2003-07-16
HUP0100531A3 (en) 2004-04-28
DK173903B1 (da) 2002-02-11
EA200200972A1 (ru) 2003-02-27
DE10108042A1 (de) 2001-10-18
NO20010619L (no) 2001-09-14
GR1003796B (el) 2002-02-08
GB2357762A (en) 2001-07-04
US20010031784A1 (en) 2001-10-18
DE60100786T2 (de) 2004-07-15
DE20007303U1 (de) 2000-07-27
NO20020356D0 (no) 2002-01-23
ITMI20002425A1 (it) 2002-05-09
SE517136C2 (sv) 2002-04-16
US20030078442A1 (en) 2003-04-24
DE60100022D1 (de) 2002-10-10
FI20010225A0 (fi) 2001-02-07
NO20010619D0 (no) 2001-02-06
ITMI20010406A1 (it) 2002-08-28
ATE223396T1 (de) 2002-09-15
BG107065A (bg) 2003-05-30
GB0105982D0 (en) 2001-05-02
IL158072A0 (en) 2004-03-28
US20050165244A1 (en) 2005-07-28
CA2360287C (en) 2003-09-09
FR2806086B1 (fr) 2003-05-09
DK1169314T3 (da) 2002-10-14
PT1227088E (pt) 2003-12-31
DE60100022T2 (de) 2003-03-06
EP1227088A1 (en) 2002-07-31
ES2159491A1 (es) 2001-10-01
YU68802A (sh) 2005-11-28
BE1013210A3 (fr) 2001-10-02
HUP0100531A2 (hu) 2002-01-28
AU2001100197A4 (en) 2001-09-20
US20040132808A1 (en) 2004-07-08
FI20010225A (fi) 2001-09-14
DK1227088T3 (da) 2003-12-22
SE0200730D0 (sv) 2002-03-12
SE526022C2 (sv) 2005-06-14

Similar Documents

Publication Publication Date Title
SI1227088T1 (en) Crystalline base of citalopram and hydrochoride or hydrobromide salt thereof
HUP0900587A3 (en) Stable salts of 3,3-diphenylpropylamines and preparation thereof
GB2365865B (en) "Method for the preparation of citalopram"
MA26845A1 (fr) Forme cristalline de 4-carboxyamino-2-ethyl-1,2,3,4-
HUP0400868A3 (en) Crystalline base of citalopram and it's hydrochloride or hydrobromide salt
HK1041878A1 (zh) 二羥吡啶化合物和其用作鉀通道開放劑的用途
HUP0101215A3 (en) Chrystalline form of paroxetine
DE59900397D1 (de) Ankerstange
TW474158U (en) Improved structure of adjustable pillow
TW529347U (en) Improved structure of fishing rod
PL339890A1 (en) Method of obtaining 4-chloro-n-(2-morpholinethyl)-benzamide
TW493422U (en) Improved structure of thermal kettle
GB0127203D0 (en) Paroxetine salt process of preparation and use thereof
TW410641U (en) Improved structure of eurhythmic rod
TW435078U (en) Improved structure of fishing rod
PL344620A1 (en) 1-alkoxymethyl-3-y-pyridinium salts and method of obtaining them _
PL107563U1 (en) Anchor rod
TW413011U (en) Improved structure of pillow
TW479453U (en) Improved structure of smoothening rod for agrimotor
TW435159U (en) Pillow of facilitating circulation of neck
TW421284U (en) Improved structure of puncher
TW370785U (en) Base structure of cap
TW488540U (en) Improved structure of buzzer